Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: J Subst Abuse Treat. 2012 Jul 2;44(2):145–158. doi: 10.1016/j.jsat.2012.05.006

Table 1. Descriptive Statistics for Characteristics of Studies Contributing Group Difference Effect Sizes (k = 73; n = 250).

Mean SD a Range
Method Characteristics
Publication year 2001 5.8 1981 - 2008
Conducted in the U.S. (1=yes) .90 .30 0 - 1
Journal publication (1=yes) .84 .37 0 - 1
Randomized design (1=yes) .99 .12 0 - 1
Average attrition rate .17 .17 0 - .70
Established survey instrument (1=yes)b .61 .49 0 - 1
Time span of outcome measure (days)b 64.9 45.3 28 - 267
Pretest-posttest interval (days) b 157.3 147.3 28 - 1456
Effect size based on means/SDs (1=yes)b .64 .48 0 - 1
Pretest group difference effect sizebc .04 .48 −1.18 - 2.57
Group equivalence effect sizec .27 .29 −.40 - 1.23
Participant Sample Characteristics
Percent male 67.8 17.6 0 - 90
Percent white 60.8 26.9 0 - 100
Age (years) 16.5 1.56 14 - 20
Clinical comorbidity (1=yes) .47 .50 0 - 1
Substance severity factor score 1.70 .61 1 - 3
Delinquency level/police contact 2.55 1.32 1 - 5
Referred from prior treatment (1=yes) .32 .47 0 - 1
Treatment Characteristics
Delivered in group format (1=yes) .32 .47 0 - 1
Level of family involvement 1.57 .64 1 - 3
Implementation quality .24 .59 −1.22 - 1.06
Duration (days) 76.4 67.5 1 - 380
Frequency of treatment contact 2.80 1.29 1 - 6

Note:

a

SD = standard deviation

b

Estimates calculated at the effect size level (n = 250); all others calculated for the k=73 group comparisons.

c

Mean estimates weighted using inverse variance weights.